This study is currently recruiting.

Description: A Randomized, Double-Blind, Placebo-Controlled, Two-Part Study of BPN14770 in Male Adolescents (Aged 9 To <18 Years) with Fragile X Syndrome.

Eligibility & Criteria

IRB #: IRB00312157

Principal Investigator: Dejan B. Budimirovic, MD

Eligible Age Range: 12 to 18 years

Gender: Male only

Diagnosis: Fragile X Syndrome